| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Oct 11, 2024 | Oct 16, 2024 | Hamill John P. SrVP CFO Prin Fin Acct Ofcr | Buy | Aprea Therapeutics, Inc. | APRE | $2.46 | $123 | +0.26% |
| Oct 10, 2024 | Oct 15, 2024 | Hamill John P. SrVP CFO Prin Fin Acct Ofcr | Buy | Aprea Therapeutics, Inc. | APRE | $2.61 | $1,175 | +2.28% |
| Mar 13, 2024 | Mar 15, 2024 | Hamill John P. SrVP CFO Prin Fin Acct Ofcr | Buy | Aprea Therapeutics, Inc. | APRE | $7.29 | $7,363 | +6.12% |
| Jul 26, 2022 | Jul 26, 2022 | Hamill John P. SVP CFO | Buy | Windtree Therapeutics Inc /de/ | WINT | $0.37 | $1,100 | +3.96% |
| Apr 16, 2021 | Apr 19, 2021 | Hamill John P. SVP CFO | Buy | Windtree Therapeutics Inc /de/ | WINT | $2.07 | $2,067 | +22.22% |
| Mar 25, 2021 | Mar 25, 2021 | Hamill John P. SVP CFO | Buy | Windtree Therapeutics Inc /de/ | WINT | $3.25 | $4,875 | +37.50% |
| Oct 07, 2020 | Oct 09, 2020 | Hamill John P. SVP CFO | Buy | Windtree Therapeutics Inc /de/ | WINT | $5.27 | $5,270 | +50.00% |
| May 31, 2019 | Jun 04, 2019 | Hamill John P. VP Fin Princ Fin Acct Officer | Buy | Trevena Inc | TRVN | $1.16 | $8,700 | +8.36% |